9-year experience in treatment of primary localized prostate cancer with robotic five-fraction ultra-hypo fractionated radiotherapy
This content is only accessible to select Accuray Exchange (AEx) members. Username Password Remember Me Forgot Password
Expanding Radixact® System Synchrony® Beyond SBRT: A Prostate Clinical Case Illustration
Xavier Michel, M.D. & Paul Retif, Ph.D., CHR Metz-Thionville, France | ESTRO 2025
CyberKnife® System for Para-Aortic/Upper Pelvic Nodal Prostate Cancer Recurrences
Sean P. Collins, M.D., Ph.D., Tampa General Hospital, FL, USA | ESTRO 2025
Adjuvant Radiation Therapy in Bladder Cancer: Why, Who and How?
Vedang Murthy, M.D., DNB, DipEPP, Tata Memorial Centre, Mumbai, India | ESTRO 2025
Emerging Data on SBRT for Primary and Oligometastatic Kidney Cancer
Nadia di Muzio, M.D., San Raffaele Scientific Institute, Milan, Italy | ESTRO 2025
Advances in Reirradiation for Prostate Cancer: Pushing the Boundaries of Precision and Efficacy
Barbara Alicja Jereczek-Fossa, M.D., Ph.D. , Department of Radiation Oncology, European Institute of Oncology, Milan, Italy | ESTRO 2025
SBRT for Localized Prostate Cancer: Evidence, Techniques, and Future Directions
Nicholas van As, M.D., The Royal Marsden NHS Foundation Trust, London, UK | ESTRO 2025
Radiothérapie stéréotaxique du cancer primitif rénal
This content is only accessible to select Accuray Exchange (AEx) members.
Retour d’expérience de l’utilisation de Synchrony® pour les traitements de prostate au Radixact®
This content is only accessible to select Accuray Exchange (AEx) members.
What unusual cases teach us: The “Art of Radiotherapy” for Clinically Localized Prostate Cancer
Mack Roach III M.D. | Professor of Radiation Oncology and Urology, University of California , San Francisco, US
